Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer-Reference-Cited by-同舟云学术

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer

Published:2022-10 Issue: Volume:65 Page:145-150
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Viansone A.,Pellegrino B.,Omarini C.,Pistelli M.,Boggiani D.,Sikokis A.,Uliana V.,Zanoni D.,Tommasi C.,Bortesi B.,Bonatti F.,Piacentini F.,Cortesi L.,Camisa R.,Sgargi P.,Michiara M.,Musolino A.

Funder

Seagen

AstraZeneca

Daiichi-Sankyo

Novartis

Eisai

Eli Lilly and Company

European Society for Medical Oncology

Pfizer

Roche

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference35 articles.

1. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

2. Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer;Musolino;Crit Rev Oncol Hematol,2020

3. Herceptin Adjuvant (HERA) Trial Study Team. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial;Cameron;Lancet,2017

4. Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials;Lancet Oncol,2021

5. Role of Fcγ receptors in HER2-targeted breast cancer therapy;Musolino;J Immunother Cancer,2022

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can contralateral prophylactic mastectomy and oophorectomy increase survival in BRCA-related breast cancer? Results from the Italian MUTina study;European Journal of Surgical Oncology;2024-10

2. BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing;British Journal of Cancer;2024-08-30

3. BRCA Mutations and MicroRNA Expression Patterns in the Peripheral Blood of Breast Cancer Patients;ACS Omega;2024-04-03

4. The Role of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapies in Early-Stage Breast Cancer: Current Practices, Treatment De-escalation, and Future Prospects;Cureus;2024-02-29

5. Contralateral Prophylactic Mastectomy and Oophorectomy Increase the Survival in Brca-Related Breast Cancer: The Italian Mutina Study;2024